Skip to main content

Table 2 IZDs (mm) of the PGF against different MRSA strains

From: Characterization of the anti-Staphylococcus aureus fraction from Penthorum chinense Pursh stems

Clinical Strains

Resistant (R)

Susceptible (S)

Intermediate (I)

IZDs

MRSA 170925062

CLI, CIP, CN, LEV, OX, PEN, SXT, TE, E, MXF

F, VAN, LZD, QD, TGC

RD

9.0 ± 0.35

MRSA 925059

OX, PEN

CLI, CIP, CN, TE, F, LEV, RD, SXT, VAN, E, MXF, LZD, QD, TGC

9.1 ± 0.43

MRSA 920057–1

CLI, CIP, CN, LEV, OX, PEN, SXT, TE, E, MXF

F, VAN, LZD, QD, TGC

RD

9.0 ± 0.74

MRSA 912036–2

CLI, CIP, CN, LEV, OX, PEN, SXT, TE, E, MXF

F, VAN, LZD, QD, TGC

RD

8.1 ± 0.43

MRSA 912037

CLI, CIP, CN, LEV, OX, PEN, SXT, TE, E, MXF

F, VAN, LZD, QD, TGC

RD

11.2 ± 0.76

MRSA 1223064–1

CLI, CIP, LEV, OX, PEN, SXT, TE, E, MXF

F, CN, VAN, LZD, QD, TGC

RD

10.4 ± 0.43

MRSA 1224057–1

CLI, CIP, LEV, OX, PEN, E, MXF

F, CN, VAN, LZD, QD, TGC, TE, RD, SXT

10.1 ± 0.75

  1. Note: “-” indicates that no visible inhibition zone was observed
  2. Abbreviations: CIP Ciprofloxacin, CLI Clindamycin, CN Cephalexin, E Erythromycin, F Nitrofurantoin, LEV Levofloxacin, LZD Linezolid, MXF Moxifloxacin, OX Oxacillin, PEN Penicillin, QD Quinupristin/dalfopristin, RD Rifampicin, SXT Sulfamethoxazole/trimethoprim, 19:1, TE Tetracycline, TGC Tigecycline, VAN Vancomycin